State of New Jersey Common Pension Fund D’s Phathom Pharmaceuticals PHAT Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio PHAT Stock Details PHAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$178K	Buy	+15,997	New	+$202K	﹤0.01%	1535

Other funds holding PHAT

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

State of New Jersey Common Pension Fund D's PHAT Position: Q1 2026 in Review

State of New Jersey Common Pension Fund D opened a new position in Phathom Pharmaceuticals (PHAT) in Q1 2026: 15,997 shares worth $178K. The stake represents ﹤0.01% of the portfolio and ranks #1535 among its holdings.

174 funds tracked by Wall St. Rank hold PHAT as of Q1 2026.

State of New Jersey Common Pension Fund D held 15,997 shares of Phathom Pharmaceuticals worth $178K as of Q1 2026.
Phathom Pharmaceuticals was a new State of New Jersey Common Pension Fund D position in Q1 2026.
Phathom Pharmaceuticals made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q1 2026, its #1535 holding.
174 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q1 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q1 2026, filed 5 May 2026.